Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Liabilities and Shareholders Equity (2020 - 2026)

IceCure Medical has reported Liabilities and Shareholders Equity over the past 7 years, most recently at $13.3 million for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $13.3 million; the TTM value through Mar 2026 reached $39.8 million, down 32.8%, while the annual FY2025 figure was $13.9 million, 10.43% up from the prior year.
  • Liabilities and Shareholders Equity was $13.3 million for Q1 2026 at IceCure Medical, down from $13.9 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $30.2 million in Q4 2022 and bottomed at $12.6 million in Q4 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $13.9 million (2025), against an average of $17.3 million.
  • Year-over-year, Liabilities and Shareholders Equity tumbled 45.64% in 2023 and then grew 10.43% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $30.2 million in 2022, then crashed by 45.64% to $16.4 million in 2023, then fell by 23.36% to $12.6 million in 2024, then rose by 10.43% to $13.9 million in 2025, then fell by 4.21% to $13.3 million in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $13.3 million (Q1 2026), $13.9 million (Q4 2025), and $12.6 million (Q4 2024) per Business Quant data.